The Osaka mutation of APP (E693 deletion) leads to the accumulation of AβO and AD pathology without the formation of senile plaques (Tomiyama et al., 2008; Nishitsuji et al., 2009; Shimada et al., 2011; Jang et al., 2013). Here, ABO is linked to Alzheimer disease.